Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The osmotic gradient across the cell membrane refers to the difference in total solute concentration (osmolarity) on either side of the cell’s plasma membrane. This gradient drives the passive movement of water (osmosis) through the membrane, usually via aquaporin water channels or directly through the lipid bilayer. The cell membrane is semipermeable, allowing for selective movement of water and some small solutes. The direction and magnitude of water flow depend on the relative concentrations of solutes inside and outside the cell. Regulation of this gradient is crucial for maintaining appropriate cell volume, intracellular environment, and overall fluid balance in tissues. Cells employ active (energy-driven) and passive transport mechanisms to control both solute and water distributions. Disrupted osmotic gradients can result in cell swelling, shrinking, lysis, or pathological states such as edema or myelinolysis. This is not a molecule, receptor, transporter, or enzyme, but a physical property or process. Dysregulation is involved in diseases related to fluid/electrolyte imbalance, e.g., hyponatremia, dehydration, cell lysis, edema, but it is not itself a discrete “target”. No drugs bind or modulate an “osmotic gradient” directly, but some drugs/solutes create or modulate osmotic gradients indirectly, such as mannitol, hypertonic saline, etc., but those act as osmotic agents rather than as classic target-based drugs. Osmotic agents change the gradient across membranes, moving water accordingly, but the gradient itself is not a molecule or protein with a mechanism of action. There is no specific biomarker for the “target,” but serum osmolality or urine osmolality may be measured to assess osmotic status. In summary, "osmotic gradient across cell membrane" is a crucial physical principle for cellular water regulation but is not itself a molecular or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic gradient across cell membrane.